These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors. Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897 [TBL] [Abstract][Full Text] [Related]
43. Synthetic Mucin-Like Glycopeptides as Versatile Tools to Measure Effects of Glycan Structure/Density/Position on the Interaction with Adhesion/Growth-Regulatory Galectins in Arrays. Artigas G; Hinou H; Garcia-Martin F; Gabius HJ; Nishimura SI Chem Asian J; 2017 Jan; 12(1):159-167. PubMed ID: 27873468 [TBL] [Abstract][Full Text] [Related]
44. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951 [TBL] [Abstract][Full Text] [Related]
45. Galectins as potential pharmacological targets in renal injuries of diverse etiology. Gu M; Mei X; Zhao Y Eur J Pharmacol; 2020 Aug; 881():173213. PubMed ID: 32450176 [TBL] [Abstract][Full Text] [Related]
46. Intracellular galectin interactions in health and disease. Jacob R; Gorek LS Semin Immunopathol; 2024 Jul; 46(1-2):4. PubMed ID: 38990375 [TBL] [Abstract][Full Text] [Related]
47. Structural basis for the recognition of carbohydrates by human galectin-7. Leonidas DD; Vatzaki EH; Vorum H; Celis JE; Madsen P; Acharya KR Biochemistry; 1998 Oct; 37(40):13930-40. PubMed ID: 9760227 [TBL] [Abstract][Full Text] [Related]
48. Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses. Hong MH; Weng IC; Li FY; Lin WH; Liu FT J Biomed Sci; 2021 Mar; 28(1):16. PubMed ID: 33663512 [TBL] [Abstract][Full Text] [Related]
49. Galectin-8: a complex sub-family of galectins (Review). Bidon N; Brichory F; Bourguet P; Le Pennec JP; Dazord L Int J Mol Med; 2001 Sep; 8(3):245-50. PubMed ID: 11494049 [TBL] [Abstract][Full Text] [Related]
50. Bi- to tetravalent glycoclusters presenting GlcNAc/GalNAc as inhibitors: from plant agglutinins to human macrophage galactose-type lectin (CD301) and galectins. André S; O'Sullivan S; Koller C; Murphy PV; Gabius HJ Org Biomol Chem; 2015 Apr; 13(14):4190-203. PubMed ID: 25721929 [TBL] [Abstract][Full Text] [Related]
51. An integrated computational analysis of the structure, dynamics, and ligand binding interactions of the human galectin network. Guardia CM; Gauto DF; Di Lella S; Rabinovich GA; Martí MA; Estrin DA J Chem Inf Model; 2011 Aug; 51(8):1918-30. PubMed ID: 21702482 [TBL] [Abstract][Full Text] [Related]
52. Role of Galectins in Multiple Myeloma. Storti P; Marchica V; Giuliani N Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207 [TBL] [Abstract][Full Text] [Related]
53. Identification of the amino acid residue in the nematode galectin LEC-1 responsible for its unique sugar binding property: analysis by combination of site-directed mutagenesis and frontal affinity chromatography. Arata Y; Ishii N; Tamura M; Nonaka T; Kasai K Biol Pharm Bull; 2007 Nov; 30(11):2012-7. PubMed ID: 17978468 [TBL] [Abstract][Full Text] [Related]
54. Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Compagno D; Tiraboschi C; Garcia JD; Rondón Y; Corapi E; Velazquez C; Laderach DJ Biomolecules; 2020 May; 10(5):. PubMed ID: 32408492 [TBL] [Abstract][Full Text] [Related]
55. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target. Smetana K; André S; Kaltner H; Kopitz J; Gabius HJ Expert Opin Ther Targets; 2013 Apr; 17(4):379-92. PubMed ID: 23289445 [TBL] [Abstract][Full Text] [Related]
56. Targeting galectin-driven regulatory circuits in cancer and fibrosis. Mariño KV; Cagnoni AJ; Croci DO; Rabinovich GA Nat Rev Drug Discov; 2023 Apr; 22(4):295-316. PubMed ID: 36759557 [TBL] [Abstract][Full Text] [Related]
57. Structural basis of multivalent galactose-based dendrimer recognition by human galectin-7. Ramaswamy S; Sleiman MH; Masuyer G; Arbez-Gindre C; Micha-Screttas M; Calogeropoulou T; Steele BR; Acharya KR FEBS J; 2015 Jan; 282(2):372-87. PubMed ID: 25367374 [TBL] [Abstract][Full Text] [Related]
58. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. André S; Liu B; Gabius HJ; Roy R Org Biomol Chem; 2003 Nov; 1(22):3909-16. PubMed ID: 14664382 [TBL] [Abstract][Full Text] [Related]
59. Structural, functional, and evolutionary aspects of galectins in aquatic mollusks: From a sweet tooth to the Trojan horse. Vasta GR; Feng C; Bianchet MA; Bachvaroff TR; Tasumi S Fish Shellfish Immunol; 2015 Sep; 46(1):94-106. PubMed ID: 25982395 [TBL] [Abstract][Full Text] [Related]
60. [Galectins in hematological malignancies--role, functions and potential therapeutic targets]. Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]